P655 The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease
I Tapiolas,M Mañosa,J Troya,S Vela,D Pares,F Mesonero,P Valera,S Riestra,E Iglesias,E Rodríguez-González,J Guardiola,S García López,D Carpio,P Vega,M D Martín Arranz,L Ramos,D Busquets,M Sierra,P Martínez Montiel,B Sicilia,E Ricart,E Garcia Planella,J M Huguet,I Vera,F Gomollon,M Rivero,L De Castro,M Barreiro de Acosta,I Rodríguez Lago,J P Gisbert,M F Garcia Sepulcre,X Calvet,F Bermejo,J L Pérez Calle,A Gutierrez,A J Lucendo,M D C Muñoz Vilafranca,M Navarro Llavat,M Calafat,E Doménech,ENEIDA,
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0785
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Colectomy is still necessary in some patients with inflammatory bowel disease (IBD). The decision of the technique for the restoration of the bowel continuity depends on the characteristics of the patient and whether it is Crohn’s disease (CD) or ulcerative colitis (UC). The options for the reconstruction are proctectomy with an ileoanal reservoir or an ileorectal anastomosis (IRa). The aim of this study is to evaluate the need of a proctectomy with a definitive ileostomy after an ileorectal anastomosis, the associated risk factors and the need for advanced therapies. Methods This retrospective study includes patients with colectomy and IRa from the ENEIDA national registry. Medical treatment offered during the postoperative follow up and the need for a proctectomy and a definitive ileostomy were evaluated according to the type of IBD. Results Of the 394 patients who underwent an IR, 37% had UC and 63% CD with a medium age of 58 years (RIQ 48-68) and a median follow-up after the IR of 174 months (RIQ 70- 266). 17% of UC’s patients and 42% of CD’s patients had associated perianal disease (p<0.001). The cumulative probability for a definitive ileostomy in UC’s patients was 1%, 2%, and 6% at 5, 10 and 20 years respectively and 1%, 3%, and 11% at 5, 10 and 20 years respectively for the CD (p=0.035). Postoperative maintenance treatment with biologicals was left in 45% (44% UC and 47% CD; p=0.28). During follow-up, the probability of starting biological treatment was 8%, 17%, 35% at 2, 5 and 10 years in CD and 3%, 12%, 28% at 2, 5 and 10 years in UC (p=0.59). Conclusion The probability of requiring a definitive ileostomy/proctectomy after an IR is low, although is more frequent in patients with CD than with UC. Because of this low probability an IR is a valid alternative to the reservoir or even to the proctectomy with a definitive ileostomy in selected patients, keeping in mind one third of the patients would need advanced therapies.
gastroenterology & hepatology